Based on Harvard and Boston Children’s Hospital research, Nocion Therapeutics has raised $27m to develop drugs for pain and inflammation.

Osage University Partners has participated in a $62m series B round for Satsuma Pharmaceuticals, which also featured Shin Nippon Biomedical Laboratories.

The first cohort of TechNovum will feature five-to-eight inventors from the institute whose concepts have been sanctioned by its tech transfer office’s 12-week validation process.

Four businesses have collected $37,000 in equity funding each from a micro-VC fund established by University of Waterloo’s Velocity unit in support of the Velocity Fund Finals competition.

Satt Ouest Valorisation has provisionally landed $22.4m of French government funding in conjunction with strategic objectives including a cost-rationalisation exercise and the expansion of its geographical remit.

University of Washington cancer diagnostics spinout Bellwether Bio has been acquired by Guardant Health, which plans to integrate the former's expertise to advance its own pipeline.

Harvard-backed Xfund is preparing to raise a third fund to follow earlier vehicles targeting companies emerging out of the Harvard and MIT ecosystems.

Deerfield Management has added yet another commercialisation fund to its roster, this time partnering University of Illinois at Chicago for a $65m vehicle.

CIC and Babraham Bioscience Technologies are among the co-founders of Start Codon, a life sciences accelerator set to invest in up to 50 seed-stage startups over the next five years.

SparkLabs Frontier-ASU will be open to student and alumni-led startups, providing an initial cohort of six-to-eight with training, mentoring and opportunities to secure funding.